Washington, D.C.—A new legislative bill is on the table that would give dietary supplement makers the ability to reference additional scientific information about the health benefits of their products.
New York, NY—Memorial Sloan-Kettering Cancer Center will launch a phase-II trial to study Maitake mushroom as a treatment for Myelodysplastic Syndrome (MDS), a category of blood diseases. Maitake has been studied previously for its effects on immune system function.
Boston, MA—Consumers are familiar with product labels touting the heart healthy benefits of eating oats. They most famously lower blood cholesterol and are an important part of a heart-healthy diet. An expanding field of research into oats and their benefits is shedding light on reasons for oats to impress even more enthusiasts.
Tours, France—Another health application of omega-3 fatty acids has been identified, this time proving a beneficial component in helping women undergoing breast cancer treatment. Specifically, docosahexaenoic acid (DHA) was found to increase the effectiveness of chemotherapy treatment for certain cases of breast cancer. The findings were published late last year in the British Journal of Cancer, and may present a means to better combat breast cancer for the millions threatened by the disease, which is the most prevalent form of cancer in women. The research was led by Philippe Bougnoux, of the Henry S. Kaplan Cancer Center in Tours.
Washington, D.C.—In the wake of the filing of a lawsuit against fish oil manufacturers over alleged polychlorinated biphenyl (PCB) contamination in their products, the Council for Responsible Nutrition (CRN), based here, released a statement defending the practices of these companies.
Washington, D.C.—Last month, WholeFoods reported on proposed legislation sponsored by Arizona Senator John McCain (R-AZ) that would redefine dietary supplements and place new burdens on the dietary supplement industry. In the weeks that followed, several industry companies and associations responded to the Dietary Supplement Safety Act (DSSA, S3.002) in full force.
Washington, D.C.—Former Presidential candidate, Senator John McCain (R-AZ), has introduced new legislation, the Dietary Supplement Safety Act of 2010, which will amend the current Federal Food, Drug, and Cosmetic Act (FD&C Act). In this bi-partisan bill, co-sponsored by Senator Byron Dorgan (D-ND), McCain seeks “to more effectively regulate dietary supplements that may pose safety risks unknown to consumers.”
Gainesville, FL—Data collected in November/December 2009 by resveratrol supplement maker ReserveAge Organics, based here, offer some illuminating insight into consumers’ attitudes with respect to this popular herb.
Alexandria, VA—Consumers who are concerned about the safety of dietary supplements should pay attention to a new statistic offered by the American Association of Poison Control Centers. According to the U.S. National Poison Data System, dietary supplements caused no deaths in 2008.
New York, NY—WholeFoods reported last month on the U.S. Food and Drug Administration’s (FDA) publication of draft guidelines concerning the distinction between beverages and liquid dietary supplements. Since then, as part of the commentary phase of the FDA guideline process, Ullman, Shapiro and Ullman, LLP have submitted a thorough response statement in opposition to the proposed FDA guidelines.